These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 2869848

  • 21. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)].
    Hata S.
    Nihon Naibunpi Gakkai Zasshi; 1977 Oct 20; 53(10):1129-39. PubMed ID: 22466
    [Abstract] [Full Text] [Related]

  • 22. Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol.
    Schulte KL, Meyer-Sabellek W, Thiede HM, Röcker L, Gotzen R.
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct 20; 25(10):539-44. PubMed ID: 3323072
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H.
    J Cardiovasc Pharmacol; 1982 Oct 20; 4(6):966-72. PubMed ID: 6185790
    [Abstract] [Full Text] [Related]

  • 25. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J, Mora-Macià J, Castellet R, del Río G.
    Med Clin (Barc); 1994 Jan 22; 102(2):41-5. PubMed ID: 8133694
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov 22; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 29. [Effect of metoprolol in patients with renal hypertension].
    Yasumoto R, Asakawa M, Kakinoki K, Umeda M, Yoshimoto M, Kawashima H, Tanabe S, Nishisaka N, Kishimoto T.
    Hinyokika Kiyo; 1988 Sep 22; 34(9):1669-73. PubMed ID: 3063110
    [Abstract] [Full Text] [Related]

  • 30. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B, Hansson L.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun 22; 20(6):291-5. PubMed ID: 7049966
    [Abstract] [Full Text] [Related]

  • 31. [The renin-angiotensin-aldosterone system in hypertensive subjects. III- The use of beta-blockers in reno-vascular hypertension (author's transl)].
    Lardoux H, Vial FS, Ménard J, Corvol P, Milliez P.
    Nouv Presse Med; 1977 Sep 17; 6(30):2659-63. PubMed ID: 20602
    [Abstract] [Full Text] [Related]

  • 32. Response of plasma immunoreactive active renin, inactive renin, plasma renin activity, and aldosterone to hemodialysis in patients with diabetic nephropathy.
    Sasamura H, Suzuki H, Takita T, Hayashi M, Ohno J, Shirai T, Saruta T.
    Clin Nephrol; 1990 Jun 17; 33(6):288-92. PubMed ID: 2198118
    [Abstract] [Full Text] [Related]

  • 33. Plasma prorenin in normal, hypertensive, and anephric subjects and its effect on renin measurements.
    Sealey JE, Moon C, Laragh JH, Atlas SA.
    Circ Res; 1977 May 17; 40(5 Suppl 1):I41-5. PubMed ID: 870230
    [Abstract] [Full Text] [Related]

  • 34. [Effect of guanabenz on arterial pressure and the renin-aldosterone system in hypertensive patients].
    Rappelli A, Glorioso N, Tedde R, Madeddu P, Dessì Fulgheri P, Campus S.
    Boll Soc Ital Cardiol; 1978 May 17; 23(1):177-83. PubMed ID: 754771
    [No Abstract] [Full Text] [Related]

  • 35. Does hormone analysis predict the antihypertensive response of basic medical treatment?
    Witzgall H, Scherer B, Lange HH, Weber PC.
    Herz; 1989 Jun 17; 14(3):197-203. PubMed ID: 2661389
    [Abstract] [Full Text] [Related]

  • 36. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate].
    Weth G, Schneider J, Rodatz H, Haubitz I.
    Arzneimittelforschung; 1985 Jun 17; 35(11):1711-3. PubMed ID: 2868733
    [Abstract] [Full Text] [Related]

  • 37. [Renin-angiotensin-aldosterone system in the treatment of essential hypertension with a beta-adrenergic blocker: sotalol].
    Psadas C, Sánchez G, Zaldívar HM, Rangel J, Cuéllar A, Serrano PA.
    Arch Inst Cardiol Mex; 1977 Jun 17; 47(2):160-70. PubMed ID: 901052
    [Abstract] [Full Text] [Related]

  • 38. Bucindolol in essential hypertension.
    Reid JL, Curzio J, Vincent J.
    Int J Clin Pharmacol Res; 1985 Jun 17; 5(5):293-301. PubMed ID: 2866166
    [Abstract] [Full Text] [Related]

  • 39. Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
    Bras H, Ochs HG, Armbruster H, Heintz R.
    Clin Nephrol; 1976 Feb 17; 5(2):57-60. PubMed ID: 943254
    [Abstract] [Full Text] [Related]

  • 40. Letter: Beta receptors and renin release.
    Amery A, Billiet L, Fagard R.
    N Engl J Med; 1974 Jan 31; 290(5):284. PubMed ID: 4148766
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.